Literature DB >> 17483831

Proposition 71 and CIRM--assessing the return on investment.

Michael T Longaker1, Laurence C Baker, Henry T Greely.   

Abstract

Given that Californian voters authorized state coffers to sell $3 billion in bonds to fund the California Institute for Regenerative Medicine (CIRM) with the expectation of health and financial benefits, what benchmarks should be used to measure the initiative's success?

Mesh:

Year:  2007        PMID: 17483831     DOI: 10.1038/nbt0507-513

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN: 1087-0156            Impact factor:   54.908


  4 in total

Review 1.  The stem cell research environment: a patchwork of patchworks.

Authors:  Timothy Caulfield; Amy Zarzeczny; Jennifer McCormick; Tania Bubela; Christine Critchley; Edna Einsiedel; Jacques Galipeau; Shawn Harmon; Michael Huynh; Insoo Hyun; Judy Illes; Rosario Isasi; Yann Joly; Graeme Laurie; Geoff Lomax; Holly Longstaff; Michael McDonald; Charles Murdoch; Ubaka Ogbogu; Jason Owen-Smith; Shaun Pattinson; Shainur Premji; Barbara von Tigerstrom; David E Winickoff
Journal:  Stem Cell Rev Rep       Date:  2009-05-27       Impact factor: 5.739

2.  Distribution of human embryonic stem cell lines: who, when, and where.

Authors:  Jennifer B McCormick; Jason Owen-Smith; Christopher Thomas Scott
Journal:  Cell Stem Cell       Date:  2009-02-06       Impact factor: 24.633

Review 3.  Stem cells and neuroprotection: understanding the players.

Authors:  Virginia Pearce
Journal:  Int J Mol Sci       Date:  2010-09-15       Impact factor: 5.923

4.  Accelerating Innovation in the Creation of Biovalue: The Cell and Gene Therapy Catapult.

Authors:  John Gardner; Andrew Webster
Journal:  Sci Technol Human Values       Date:  2017-04-06
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.